PPARγ maintains ERBB2-positive breast cancer stem cells.
about
Role of nuclear receptors in breast cancer stem cellsAntioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem CellsAcetylation-defective mutant of Pparγ is associated with decreased lipid synthesis in breast cancer cellsMetformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193bPalmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cellsLipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells.Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer.PPARG is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic targetBruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells.Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.Metabolic Assays for Detection of Neutral Fat Stores.Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice.Unsaturated fatty acids regulate stemness of ovarian cancer cells through NF-κB.A novel interaction of PAK4 with PPARγ to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma.ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.The Anticancer Potential of Peroxisome Proliferator-Activated Receptor Antagonists.Peroxisome Proliferator-Activated Receptor γ and PGC-1α in Cancer: Dual Actions as Tumor Promoter and Suppressor.Global metabolite profiling analysis of lipotoxicity in HER2/neu-positive breast cancer cells.
P2860
Q26750359-058D01CA-DE08-4E17-84E3-8D752A261C95Q26853528-BA473296-58E7-42AB-A6E4-FF3F5FAC658DQ34365660-E4E4C1D2-6421-4FED-9BCD-1D30654C89BBQ36062114-6FAD1BCC-1C71-4BB7-BAF8-0B76FE43EE1DQ36087653-E523A557-B528-4955-BE32-C3BE81BC66D4Q36237226-019A0B41-2E67-41E4-96BE-E033378F954CQ37627650-B626E793-CDA7-426E-B902-1EDE6E6B9D66Q37734001-883516EB-DC7F-4028-A5ED-AAAD1C30A4FAQ38766891-E1969C0F-746B-47F7-BF95-42BD7EB19BD2Q39251611-D73D0FC7-A52A-4C1F-8C7E-3257B4931E6EQ42051009-73317CC5-31A7-41C6-8911-5DC5FD28FD02Q42201182-CDB9F3AD-A034-48E1-8043-4CD8B4DD0A12Q42342126-3F2923E6-DB97-41F8-BCDD-17C37E3C28E2Q46362056-94CCDE2F-E853-49AA-8457-ABF797BC7C7AQ47118535-8A31B33B-F1EB-4298-A704-252CA2269FF9Q48350605-C715DCB6-0364-444B-AD8E-8C828007D246Q53076500-C9B2D7B4-634F-44D5-9066-FA39F1B1EECAQ55284992-BB101D41-4488-4D6A-A89A-24BAA3122C84
P2860
PPARγ maintains ERBB2-positive breast cancer stem cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PPARγ maintains ERBB2-positive breast cancer stem cells.
@en
PPARγ maintains ERBB2-positive breast cancer stem cells.
@nl
type
label
PPARγ maintains ERBB2-positive breast cancer stem cells.
@en
PPARγ maintains ERBB2-positive breast cancer stem cells.
@nl
prefLabel
PPARγ maintains ERBB2-positive breast cancer stem cells.
@en
PPARγ maintains ERBB2-positive breast cancer stem cells.
@nl
P2093
P2860
P356
P1433
P1476
PPARγ maintains ERBB2-positive breast cancer stem cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.217
P407
P577
2013-06-17T00:00:00Z
P5875
P6179
1000849796